Inhaled Insulin Product Approved

Posted in Pharmacy Industry News

In June, the FDA approved the inhaled insulin product created by MannKind Corp, Afrezza Inhalation Powder, for preprandial use in patients who have type 1 or 2 diabetes. Afrezza is...
» More